Enhancing Natriuretic Peptide Bioactivity Prevents Bleomycin-Induced Pulmonary Fibrosis

BMC Pharmacology
doi 10.1186/1471-2210-11-s1-p3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Glycyrrhizic Acid Alleviates Bleomycin-Induced Pulmonary Fibrosis in Rats

Frontiers in Pharmacology
Pharmacology
2015English

Prostaglandin D2 Attenuates Bleomycin-Induced Lung Inflammation and Pulmonary Fibrosis

PLoS ONE
Multidisciplinary
2016English

E- And P-Selectins Synergistically Inhibit Bleomycin-Induced Pulmonary Fibrosis

American Journal of Pathology
Forensic MedicinePathology
2006English

Implantation of Fetal Rat Lung Fragments Into Bleomycin-Induced Pulmonary Fibrosis

Journal of Thoracic and Cardiovascular Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2012English

High Endogenous Activated Protein C Levels Attenuates Bleomycin-Induced Pulmonary Fibrosis

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2016English

Roflumilast Prevents the Metabolic Effects of Bleomycin-Induced Fibrosis in a Murine Model

PLoS ONE
Multidisciplinary
2015English

C-Type Natriuretic Peptide Prevents Angiotensin II-induced Cardiac Remodelling and Dysfunction

BMC pharmacology & toxicology
MedicinePharmacology
2015English

Blockade of the WNT/Β-Catenin Pathway Attenuates Bleomycin-Induced Pulmonary Fibrosis

Tohoku Journal of Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
2011English

Role of Histamine H 4 Receptor Ligands in Bleomycin-Induced Pulmonary Fibrosis

Pharmacological Research
Pharmacology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy